A phase 1, multicenter, open-label, safety study of a PNK-007 infusion following autologous stem cell transplant for multiple myeloma - Regional Cancer Care Associates LLC

Clinical Trials

A phase 1, multicenter, open-label, safety study of a PNK-007 infusion following autologous stem cell transplant for multiple myeloma

Type of Cancer

Warning: implode(): Invalid arguments passed in /home/region33/public_html/wp-content/themes/regionalcancercenter/single-clinical-trials.php on line 42
Locations
Sponsor
Celgene
Protocol Number
Celgene CCT-PNK-007-MM-001
Cancer Diagnosis
To Learn More Call
201-510-0910